Fellow of The Academy of Medical Sciences, United Kingdom
His primary areas of study are Diabetes mellitus, Type 2 diabetes, Internal medicine, Gerontology and Physical therapy. Particularly relevant to Type 2 Diabetes Mellitus is his body of work in Diabetes mellitus. His biological study spans a wide range of topics, including Meta-analysis, Retrospective cohort study, Cohort study and Weight loss.
His research in Internal medicine intersects with topics in Placebo, Endocrinology and Cardiology. His Gerontology research includes elements of Cross-sectional study, Longitudinal study and Demography. His Physical therapy research incorporates themes from Overweight, Randomized controlled trial and Sitting.
Kamlesh Khunti mainly focuses on Type 2 diabetes, Diabetes mellitus, Internal medicine, Type 2 Diabetes Mellitus and Family medicine. His Type 2 diabetes study combines topics from a wide range of disciplines, such as Metformin, Insulin, Gerontology, Randomized controlled trial and Physical therapy. Physical therapy is closely attributed to Sitting in his work.
His studies in Diabetes mellitus integrate themes in fields like Surgery, Primary care, Intensive care medicine, Disease and Pediatrics. His Internal medicine research is multidisciplinary, relying on both Endocrinology and Cardiology. Kamlesh Khunti has researched Body mass index in several fields, including Demography and Obesity.
Kamlesh Khunti mostly deals with Type 2 diabetes, Internal medicine, Diabetes mellitus, Coronavirus disease 2019 and Pandemic. His work deals with themes such as Metformin, Research design, Disease, Hazard ratio and Type 2 Diabetes Mellitus, which intersect with Type 2 diabetes. His study in Internal medicine concentrates on Retrospective cohort study, Meta-analysis, Blood pressure, Myocardial infarction and Stroke.
Kamlesh Khunti combines subjects such as Observational study, Kidney disease, Intensive care medicine, Insulin and Pediatrics with his study of Diabetes mellitus. His work in Coronavirus disease 2019 addresses issues such as Demography, which are connected to fields such as Cohort study, Obesity, Confidence interval, Odds ratio and Body mass index. The concepts of his Pandemic study are interwoven with issues in Health care, Public health and Environmental health.
Kamlesh Khunti focuses on Coronavirus disease 2019, Diabetes mellitus, Internal medicine, Type 2 diabetes and Pandemic. The various areas that he examines in his Coronavirus disease 2019 study include Retrospective cohort study, Family medicine and Environmental health. His work carried out in the field of Diabetes mellitus brings together such families of science as Heart failure, Kidney disease, Intensive care medicine, Pediatrics and Risk factor.
His Meta-analysis, Disease, Body mass index, Blood pressure and Relative risk investigations are all subjects of Internal medicine research. The study incorporates disciplines such as Therapeutic inertia, Weight loss, Randomized controlled trial, Propensity score matching and Type 2 Diabetes Mellitus in addition to Type 2 diabetes. Impaired fasting glucose and Impaired glucose tolerance is closely connected to Publication bias in his research, which is encompassed under the umbrella topic of Type 2 Diabetes Mellitus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis
Emma G Wilmot;Charlotte L Edwardson;Charlotte L Edwardson;Felix A Achana;Melanie J Davies;Melanie J Davies;Melanie J Davies.
The prevalence of co‐morbid depression in adults with Type 2 diabetes: a systematic review and meta‐analysis
S. Ali;M. A. Stone;J. L. Peters;M. J. Davies.
Diabetic Medicine (2006)
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
Clare Louise Gillies;Keith R. Abrams;Paul C. Lambert;Nicola J. Cooper.
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
Francesco Cosentino;Peter J Grant;Victor Aboyans;Clifford J Bailey.
European Heart Journal (2020)
Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial
Melanie J. Davies;S. Heller;T.C. Skinner;M.J. Campbell.
Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis
Patrice Carter;Laura J Gray;Jacqui Troughton;Kamlesh Khunti.
web science (2010)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Salim Yusuf;Jackie Bosch;Gilles Dagenais;Jun Zhu.
The New England Journal of Medicine (2016)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Mikhail Kosiborod;Matthew A. Cavender;Alex Z. Fu;John P. Wilding.
Practical recommendations for the management of diabetes in patients with COVID-19.
Stefan R. Bornstein;Francesco Rubino;Francesco Rubino;Kamlesh Khunti;Geltrude Mingrone;Geltrude Mingrone.
The Lancet Diabetes & Endocrinology (2020)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Eva M. Lonn;Eva M. Lonn;Jackie Bosch;Jackie Bosch;Patricio Lopez-Jaramillo;Jun Zhu.
The New England Journal of Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: